Showing results (121-130 of 144) with videos related to
Sort By:
Pageof 15
Brain Research|December 6, 1991
Autoradiographic distribution of alpha 2 adrenoceptors, NAIBS, and 5-HT1A receptors in human brain using [3H]idazoxan and [3H]rauwolscineH De Vos, A Convents, J De Keyser, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 3, 2008
Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory studyJ P Mostert, F Admiraal-Behloul, J M Hoogduin, et al.Cephalalgia : an International Journal of Headache|February 1, 1994
Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal studyJ Schoenen, J Bulcke, J Caekebeke, et al.Acta Neurologica Scandinavica|April 5, 2013
Performance on Paced Auditory Serial Addition Test and cerebral blood flow in multiple sclerosisM D'haeseleer, C Steen, J M Hoogduin, et al.Cell Death & Disease|December 6, 2014
RIPK1 promotes death receptor-independent caspase-8-mediated apoptosis under unresolved ER stress conditionsY Estornes, M A Aguileta, C Dubuisson, et al.Neurology|October 14, 2005
A randomized crossover study of bee sting therapy for multiple sclerosisT Wesselius, D J Heersema, J P Mostert, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1997
Risks of multiple sclerosis in relatives of patients in Flanders, BelgiumH Carton, R Vlietinck, J Debruyne, et al.Catheterization and Cardiovascular Diagnosis|June 1, 1997
Brachial, radial, or femoral approach for elective Palmaz-Schatz stent implantation: a randomized comparisonE Benit, L Missault, T Eeman, et al.Clinical Therapeutics|January 28, 1998
Safety and pharmacokinetics of the neuroprotective drug lubeluzole in patients with ischemic strokeJ De Keyser, V Van de Velde, R L Schellens, et al.Pageof 15